Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on June 18, 2025
F2G Announces Publication in The Lancet Infectious Diseases of Phase 2b Data Demonstrating Positive Therapeutic Responses in Patients with Serious Invasive Fungal Diseases Treated with Oral Olorofim
GlobeNewswire
·
June 18, 2025
MANCHESTER, United Kingdom, June 18, 2025 (GLOBE NEWSWIRE) -- F2G Ltd, a clinical-stage biopharmaceutical company developing olorofim, a novel therapy to treat life-threatening rare fungal infections with high unmet medical need, today announced the …
Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System
GlobeNewswire
·
June 18, 2025
PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food and Drug Administration (FDA) for the development of its …
Gradient Denervation Technologies annonce son admission au programme consultatif de la FDA sur le cycle de vie complet des produits pour le développement de son système de dénervation de l’artère pulmonaire
GlobeNewswire
·
June 18, 2025
PARIS, 18 juin 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies annonce ce jour son admission au programme pilote TAP (Total Product Life Cycle Advisory Program, programme consultatif sur le cycle de vie complet des produits) de la Food and Drug …
Goliath Resources Closes Concurrent C$4,062,500 Non-Brokered CFT Share Financing At C$3.17 Each For Combined Gross Proceeds of C$27,065,605
GlobeNewswire
·
June 18, 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 18, 2025 (GLOBE NEWSWIRE) -- Further to its news releases dated June 2, 2025, …
Microchip Enhances Digital Signal Controller Lineup with Industry-Leading PWM Resolution and ADC Speed
GlobeNewswire
·
June 18, 2025
CHANDLER, Ariz., June 18, 2025 (GLOBE NEWSWIRE) -- Evolving security and functional safety demands, coupled with the growing complexity of real-time embedded applications, are driving designers to seek innovative solutions that deliver greater accuracy, …
Troilus Agrees to Commercial Offtake Terms with Aurubis for Its Copper-Gold Concentrate
GlobeNewswire
·
June 18, 2025
MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”) (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce that is has agreed to indicative commercial offtake terms with Aurubis AG (“Aurubis”), a leading global …
Troilus s’entend sur les modalités commerciales d’approvisionnement avec Aurubis pour son concentré de cuivre-or
GlobeNewswire
·
June 18, 2025
MONTRÉAL, 18 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer qu’elle s’est entendue sur des modalités commerciales indicatives d’approvisionnement avec Aurubis AG …
Resultados operativos sólidos de la instalación de litio fortalecen la preparación comercial de la extracción directa de litio (DLE) de Summit Nanotech
GlobeNewswire
·
June 18, 2025
DENVER, June 18, 2025 (GLOBE NEWSWIRE) -- Summit Nanotech Corporation ("Summit") se enorgullece en anunciar el primer aniversario de operaciones de su sistema de extracción directa de litio (DLE) en EE. UU., que integra columnas de altura comercial y un …
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Receptor Agonist, in China
GlobeNewswire
·
June 18, 2025
BOSTON and SHANGHAI, June 18, 2025 (GLOBE NEWSWIRE) -- Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced that the first …
Adant and QuantalRF Partner to Advance Antenna Performance in Wi-Fi Access Points
GlobeNewswire
·
June 18, 2025
PLEASANTON, Calif. and ZURICH, June 18, 2025 (GLOBE NEWSWIRE) -- Adant Technologies Inc., a global leader in smart antenna solutions for wireless connectivity, today announced a strategic partnership with QuantalRF, the pioneering developer of RF …
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
GlobeNewswire
·
June 18, 2025
WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company focused on the treatment of immune dysregulation, today announced the appointment of Rita Jain, M.D. to its Board of Directors. “ …
I-Mab to Host Webinar to Recap New Givastomig Data, in Combination with Immunochemotherapy, Expected at ESMO GI 2025
GlobeNewswire
·
June 18, 2025
Virtual investor event planned for July 8th at 2:00pm EDT Event to follow presentation of new Phase 1b combination dose escalation data for givastomig (Claudin 18.2 x 4-1BB bispecific antibody) at ESMO GI on July 2, 2025 ROCKVILLE, Md., June 18, 2025 ( …
Climb Channel Solutions Announces North American Alliance with Bugcrowd
GlobeNewswire
·
June 18, 2025
EATONTOWN, N.J., June 18, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) is pleased to announce a new North American …
Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
GlobeNewswire
·
June 18, 2025
Nutriband and Kindeva have completed commercial manufacturing process scale-up for its lead product Aversa™ Fentanyl, an abuse-deterrent fentanyl patch Nutriband is partnering with Kindeva to develop Aversa™ Fentanyl which combines Nutriband’s Aversa™ …
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
GlobeNewswire
·
June 18, 2025
WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying cause of intractable genetic diseases, today announced …
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week Interim Data
GlobeNewswire
·
June 18, 2025
Phase 3 TransportNPC study to continue based on the independent DMC review of safety and efficacy data at prespecified 48-week interim analysis Data on the investigational candidate Trappsol® Cyclo™ (hydroxypropyl-beta-cyclodextrin), indicates that it is …
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
GlobeNewswire
·
June 18, 2025
Robust intellectual property portfolio, built over more than a decade, designed to protect core innovations for treating metabolic diseases New U.S. patents strengthen Fractyl’s leadership in metabolic innovation by expanding its patent coverage of …
Gogo successfully completes first 5G end-to-end call.
GlobeNewswire
·
June 18, 2025
Broomfield, CO., June 18, 2025 (GLOBE NEWSWIRE) -- Broomfield, CO./ June 18, 2025 – Gogo (NASDAQ: GOGO) confirms today that GCT Semiconductor has successfully completed the very first end-to-end call using its next-generation 5G technology. The call, which …
Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration
GlobeNewswire
·
June 18, 2025
MONTREAL, June 18, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; FRANKFURT:1XQ; “BRW” or the “Company”) is pleased to announce it has launched an aggressive regional-scale prospecting and mapping initiative on its sizeable …
Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer
GlobeNewswire
·
June 18, 2025
Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise Company Also Hires Cindy J. Driscoll, MBA, Financial Executive with Over Two Decades of …